Mineralys Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 6K | 0 | 15K | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -6K | 0 | -15K | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 24.4M | 24.4M | 31.4M | 38.3M | 37.9M | 44.6M | 54.0M | 39.3M |
| Operating Expenses | 45.3M | 38.3M | 41.1M | 46.7M | 44.4M | 51.8M | 60.1M | 45.2M |
| Operating Income | -45.3M | -38.3M | -41.1M | -46.7M | -44.4M | -51.8M | -60.1M | -45.2M |
| Other Income / Gains | 6.0M | 6.0M | 4.2M | 3.5M | 2.2M | 2.8M | 3.8M | 4.2M |
| Net Income | -39.3M | -32.2M | -36.9M | -43.3M | -42.2M | -48.9M | -56.3M | -41.0M |
| EPS (Diluted) | -0.47 | -0.40 | -0.52 | -0.66 | -0.79 | -0.98 | -1.13 | -0.83 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 21.0M | 13.9M | 9.7M | 8.5M | 6.6M | 7.2M | 6.1M | 5.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 21.0M | 13.9M | 9.7M | 8.5M | 6.6M | 7.2M | 6.1M | 5.9M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 45.3M | 38.3M | 41.1M | 46.7M | 44.4M | 51.8M | 60.1M | 45.2M |
| Interest Income | 6.0M | 6.0M | 4.2M | 3.5M | 2.2M | 2.8M | 3.8M | 4.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 6K | 13K | 15K | 16K | 15K | 15K | 11K | 9K |
| Ebitda | -39.3M | -32.2M | -36.9M | -43.3M | -42.2M | -48.9M | -56.3M | -41.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -39.3M | -32.2M | -36.9M | -43.3M | -42.2M | -48.9M | -56.3M | -41.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.47 | -0.40 | -0.52 | -0.66 | -0.79 | -0.98 | -1.13 | -0.83 |
| Weighted Average Shs Out | 82.8M | 80.5M | 70.6M | 65.5M | 53.2M | 50.0M | 49.8M | 49.4M |
| Weighted Average Shs Out Dil | 82.8M | 80.5M | 70.6M | 65.5M | 53.2M | 50.0M | 49.8M | 49.4M |